“Lynch Syndrome, Colorectal Cancer, and Immunotherapy in a 19-Year-Old Female: Personalized Treatment Strategies for Early-Onset Cancer”

https://pubmed.ncbi.nlm.nih.gov/38094538

A 19-year-old female with Lynch syndrome developed advanced colorectal cancer and had a significant response to pembrolizumab immunotherapy, highlighting the importance of genetic predisposition and personalized treatment strategies in managing early-onset colorectal cancer.